| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Bankruptcy > Chapter 13 Bankruptcy Cases |
|
Advice You - Chapter 13 Bankruptcy Cases
Chapter 13 is for individuals with a standard income, keeping in mind their intention to p According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ay their debts but are unable to do so in a timely manner. The rationale of Chapter 13 is ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in to facilitate financially distressed individual debtors to propose and carry out a settlem lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ent plan under which creditors are paid over an extended period of time. According to thi here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe chapter, debtors are permitted to pay off creditors, in full or in part, over a three-to d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro five-year period, during which time creditors are prohibited from starting or continuing c ucts have become life saving products for the pharmaceutical companies who doesnt have many innovative molecules in their product pipeline and have been inc ollection efforts. A plan providing for payments over more than three years must be for a easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi eason and must be approved by the court. Under no condition may a plan provide for payment nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically s over a period that is longer than five years. Any person, even if self-employed or oper and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ating an unincorporated business is qualified for Chapter 13 aid. Eligibility is dependent ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the person?s unsecured and secured debts adjusted annually by statute. A company or partne ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a rship is not generally permitted to be a Chapter 13 debtor. This chapter considers six as dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod pects of a Chapter 13 proceeding. It deals with the advantages of choosing chapter 13, the cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin Chapter 13 eligibility requirements and how a Chapter 13 proceeding works. It also takes tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nto account factors that may be included in a Chapter 13 repayment plan, its confirmation, t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel making the plan work, and the particular Chapter 13 discharge. Chapter 13 bankruptcy, un ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust like Chapter 7, does not completely discharge a person?s debt. Instead, under a Chapter 13 y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products plan, people use their income to pay back some or all of what they owe to their creditors, . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de generally in a three-year time period. To file for Chapter 13 Bankruptcy, you must have a elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip stable income, secured debts less than $870,000 and unsecured debts of less than $290,000 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:4 Steps to Make Money With Internet and Online Business List Building - Building Responsive Lists
|